Enveric Biosciences Sees Opportunity In Both Cannabinoids, Psychedelics

Green Market Report recently spoke with Enveric Biosciences (NASDAQ: ENVB) CEO Dr. Joseph Tucker at the Microdose Wonderland conference in Miami. Dr. Tucker sees room for both cannabinoids and psychedelics within the company. He also believes there are several areas for patients with needs that are currently unmet and Enveric looks to address those conditions.

Video Staff


Leave a Reply

Your email address will not be published. Required fields are marked *

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 6 hours

The Daily Hit: September 28, 2022

@GreenMarketRpt – 8 hours

Cann Ventures Into CBD Beverages, But Looking Beyond CBD

@GreenMarketRpt – 12 hours

Ascend Wellness Appoints Interim Co-CEO’s in Wake of Battery Charge

Back to Top

Choose Your News

Subscribe to the Green Market Report newsletter that gives you original content delivered straight to your inbox.

 Subscribe

We respect your privacy. See our privacy policy.